Earnings Feed
Start Free
Home/Filings/4/0001209191-12-057907
4//SEC Filing

CONWAY ANTHONY J 4

Accession 0001209191-12-057907

CIK 0000868368other
View on SEC.govCompany Profile

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 6:50 PM ET

Size

21.0 KB

Accession

0001209191-12-057907

Insider Transaction Report

Form 4
Period: 2012-12-12
ROCHESTER MEDICAL CORPORATIONROCM
CONWAY ANTHONY J
DirectorPresident and Secretary
Transactions
  • Exercise/Conversion

    Common Stock

    2012-12-12$4.13/sh+16,000$66,000→ 822,404 total
  • Sale

    Common Stock

    2012-12-12$9.90/sh−16,000$158,400→ 806,404 total
  • Exercise/Conversion

    Stock Option (Right to Buy

    2012-12-12−16,000→ 0 total
    Exercise: $4.13From: 2004-01-02Exp: 2013-01-02→ Common Stock (16,000 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $11.27From: 2010-02-03Exp: 2019-02-03→ Common Stock (30,000 underlying)
    30,000

  • Stock Option (Right to Buy)

    Exercise: $4.63From: 2005-01-02Exp: 2014-01-02→ Common Stock (16,000 underlying)
    16,000

  • Stock Option (Right to Buy)

    Exercise: $5.70From: 2007-01-26Exp: 2016-01-26→ Common Stock (1,844 underlying)
    1,844

  • Stock Option (Right to Buy)

    Exercise: $12.30From: 2007-11-21Exp: 2016-11-21→ Common Stock (40,000 underlying)
    40,000

  • Stock Option (Right to Buy)

    Exercise: $11.23From: 2009-02-06Exp: 2018-02-06→ Common Stock (30,000 underlying)
    30,000

  • Stock Option (Right to Buy)

    Exercise: $12.27From: 2011-01-28Exp: 2020-01-28→ Common Stock (30,000 underlying)
    30,000

  • Common Stock

    (indirect: By Spouse)
    63,755

  • Stock Option (Right to Buy)

    Exercise: $4.70From: 2006-01-01Exp: 2015-01-01→ Common Stock (40,000 underlying)
    40,000

  • Stock Option (Right to Buy)

    Exercise: $10.72From: 2012-01-27Exp: 2021-01-27→ Common Stock (30,000 underlying)
    30,000

  • Stock Option (Right to Buy)

    Exercise: $5.70From: 2007-01-26Exp: 2016-01-26→ Common Stock (18,156 underlying)
    18,156
Footnotes (4)
  • [F1]The price in Column 4 is a weighted average. The prices actually received ranged from $9.86 to $9.95. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F2]Vest as to 25% annual cumulative installments beginning one year from date of grant, beginning the date shown.
  • [F3]100% vested on 1/26/2007.
  • [F4]Vest 3,156 shares on 1/26/2007 and annual cumulative installments of 5,000 beginning 1/26/2008.

Documents

1 file

Issuer

ROCHESTER MEDICAL CORPORATION

CIK 0000868368

→
Entity typeother

Related Parties

1
  • filerCIK 0001033088

Filing Metadata

Form type
4
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 6:50 PM ET
Size
21.0 KB
View on SEC.gov